{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T09:43:37Z","timestamp":1790761417213,"version":"4.1.0"},"reference-count":39,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2007,12,1]]},"DOI":"10.1097\/qai.0b013e3181594c8c","type":"journal-article","created":{"date-parts":[[2009,3,3]],"date-time":"2009-03-03T23:43:42Z","timestamp":1236123822000},"page":"456-462","source":"Crossref","is-referenced-by-count":144,"title":["Immune Reconstitution Inflammatory Syndrome"],"prefix":"10.1097","volume":"46","author":[{"given":"Yukari C","family":"Manabe","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James D","family":"Campbell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily","family":"Sydnor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard D","family":"Moore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-12-20210131","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/S0140-6736(03)13802-0","article-title":"Decline in the AIDS and death rates in the EuroSIDA study: an observational study.","volume":"362","author":"Mocroft","year":"2003","journal-title":"Lancet"},{"key":"R2-12-20210131","doi-asserted-by":"crossref","first-page":"447","DOI":"10.7326\/0003-4819-133-6-200009190-00013","article-title":"Inflammatory reactions in HIV-1-infected persons after initiation of highly active antiretroviral therapy.","volume":"133","author":"DeSimone","year":"2000","journal-title":"Ann Intern Med"},{"key":"R3-12-20210131","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1086\/383034","article-title":"Immune reconstitution in HIV-infected patients.","volume":"38","author":"Hirsch","year":"2004","journal-title":"Clin Infect Dis"},{"key":"R4-12-20210131","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1097\/01.aids.0000131375.21070.06","article-title":"Immune restoration disease after antiretroviral therapy.","volume":"18","author":"French","year":"2004","journal-title":"AIDS"},{"key":"R5-12-20210131","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1093\/jac\/dki444","article-title":"Immune reconstitution inflammatory syndrome: more answers, more questions.","volume":"57","author":"Shelburne","year":"2006","journal-title":"J Antimicrob Chemother"},{"key":"R6-12-20210131","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1086\/503903","article-title":"Immune reconstitution syndrome in HIV: validating a case definition and identifying clinical predictors in persons initiating antiretroviral therapy.","volume":"42","author":"Robertson","year":"2006","journal-title":"Clin Infect Dis"},{"key":"R7-12-20210131","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1111\/j.1468-1293.2005.00277.x","article-title":"The prevalence and risk of immune restoration disease in HIV-infected patients treated with highly active antiretroviral therapy.","volume":"6","author":"Jevtovic","year":"2005","journal-title":"HIV Med"},{"key":"R8-12-20210131","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1046\/j.1468-1293.2000.00012.x","article-title":"Immune restoration disease after the treatment of immunodeficient HIV-infected patients with highly active antiretroviral therapy.","volume":"1","author":"French","year":"2000","journal-title":"HIV Med"},{"key":"R9-12-20210131","first-page":"408","article-title":"Immune restoration disease in HIV-infected individuals receiving highly active antiretroviral therapy: clinical and immunological characteristics.","volume":"61","author":"de Boer","year":"2003","journal-title":"Neth J Med"},{"key":"R10-12-20210131","doi-asserted-by":"crossref","first-page":"1709","DOI":"10.1086\/425742","article-title":"Determinants of immune reconstitution inflammatory syndrome in HIV type 1-infected patients with tuberculosis after initiation of antiretroviral therapy.","volume":"39","author":"Breton","year":"2004","journal-title":"Clin Infect Dis"},{"key":"R11-12-20210131","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1164\/ajrccm.158.1.9712001","article-title":"Paradoxical worsening of tuberculosis following antiretroviral therapy in patients with AIDS.","volume":"158","author":"Narita","year":"1998","journal-title":"Am J Respir Crit Care Med"},{"key":"R12-12-20210131","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1001\/archinte.162.1.97","article-title":"Paradoxical reactions of tuberculosis in patients with the acquired immunodeficiency syndrome who are treated with highly active antiretroviral therapy.","volume":"162","author":"Navas","year":"2002","journal-title":"Arch Intern Med"},{"key":"R13-12-20210131","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1097\/01.aids.0000161769.06158.8a","article-title":"Incidence and risk factors for immune reconstitution inflammatory syndrome during highly active antiretroviral therapy.","volume":"19","author":"Shelburne","year":"2005","journal-title":"AIDS"},{"key":"R14-12-20210131","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/S1473-3099(06)70463-7","article-title":"Immunological recovery and antiretroviral therapy in HIV-1 infection.","volume":"6","author":"Battegay","year":"2006","journal-title":"Lancet Infect Dis"},{"key":"R15-12-20210131","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1086\/499356","article-title":"Incidence and risk factors for immune reconstitution inflammatory syndrome in an ethnically diverse HIV type 1-infected cohort.","volume":"42","author":"Ratnam","year":"2006","journal-title":"Clin Infect Dis"},{"key":"R16-12-20210131","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/j.crad.2003.12.002","article-title":"Immune reconstitution inflammatory syndrome in HIV-infected patients with mycobacterial infections starting highly active anti-retroviral therapy.","volume":"59","author":"Buckingham","year":"2004","journal-title":"Clin Radiol"},{"key":"R17-12-20210131","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1097\/00005792-200205000-00005","article-title":"3rd, Hamill RJ, Rodriguez-Barradas MC, et al. Immune reconstitution inflammatory syndrome: emergence of a unique syndrome during highly active antiretroviral therapy.","volume":"81","author":"Shelburne","year":"2002","journal-title":"Medicine (Baltimore)"},{"key":"R18-12-20210131","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1097\/QAD.0b013e328011efac","article-title":"Tuberculosis-associated immune reconstitution disease: incidence, risk factors and impact in an antiretroviral treatment service in South Africa.","volume":"21","author":"Lawn","year":"2007","journal-title":"AIDS"},{"key":"R19-12-20210131","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1136\/thx.2003.019224","article-title":"Paradoxical reactions during tuberculosis treatment in patients with and without HIV co-infection.","volume":"59","author":"Breen","year":"2004","journal-title":"Thorax"},{"issue":"Suppl 1","key":"R20-12-20210131","doi-asserted-by":"crossref","first-page":"S38","DOI":"10.1097\/00042560-199801001-00011","article-title":"Understanding the clinical and economic outcomes of HIV therapy: the Johns Hopkins HIV Clinical Practice Cohort.","volume":"17","author":"Moore","year":"1998","journal-title":"J Acquir Immune Defic Syndr Hum Retrovirol"},{"key":"R21-12-20210131","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1097\/01.aids.0000176221.33237.67","article-title":"Does immune reconstitution syndrome promote active tuberculosis in patients receiving highly active antiretroviral therapy?","volume":"19","author":"Breen","year":"2005","journal-title":"AIDS"},{"key":"R22-12-20210131","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/S1473-3099(05)70140-7","article-title":"Immune reconstitution disease associated with mycobacterial infections in HIV-infected individuals receiving antiretrovirals.","volume":"5","author":"Lawn","year":"2005","journal-title":"Lancet Infect Dis"},{"key":"R23-12-20210131","doi-asserted-by":"crossref","first-page":"e289","DOI":"10.1016\/j.jinf.2005.02.031","article-title":"Cryptococcal immune reconstitution inflammatory syndrome: report of four cases in three patients and review of the literature.","volume":"51","author":"Skiest","year":"2005","journal-title":"J Infect"},{"key":"R24-12-20210131","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1258\/0956462052932647","article-title":"Fatal Kaposis sarcoma-associated immune reconstitution following HAART initiation.","volume":"16","author":"Crane","year":"2005","journal-title":"Int J STD AIDS"},{"key":"R25-12-20210131","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1089\/apc.2005.19.635","article-title":"Recrudescent Kaposis sarcoma after initiation of HAART: a manifestation of immune reconstitution syndrome.","volume":"19","author":"Leidner","year":"2005","journal-title":"AIDS Patient Care STDS"},{"key":"R26-12-20210131","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/S0002-9343(01)00703-3","article-title":"Herpes zoster as an immune reconstitution disease after initiation of combination antiretroviral therapy in patients with human immunodeficiency virus type-1 infection.","volume":"110","author":"Domingo","year":"2001","journal-title":"Am J Med"},{"key":"R27-12-20210131","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1177\/135965350501000303","article-title":"Clinical characteristics of IRIS syndrome in patients with HIV and tuberculosis.","volume":"10","author":"Michailidis","year":"2005","journal-title":"Antivir Ther"},{"key":"R28-12-20210131","first-page":"71","article-title":"Paradoxical responses in a cohort of HIV-1-infected patients with mycobacterial disease.","volume":"6","author":"Olalla","year":"2002","journal-title":"Int J Tuberc Lung Dis"},{"key":"R29-12-20210131","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/S1473-3099(06)70530-8","article-title":"The immunopathogenesis of mycobacterial immune restoration disease.","volume":"6","author":"French","year":"2006","journal-title":"Lancet Infect Dis"},{"key":"R30-12-20210131","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1086\/497269","article-title":"Nontuberculous mycobacterial immune reconstitution syndrome in HIV-infected patients: spectrum of disease and long-term follow-up.","volume":"41","author":"Phillips","year":"2005","journal-title":"Clin Infect Dis"},{"key":"R31-12-20210131","doi-asserted-by":"crossref","first-page":"13878","DOI":"10.1073\/pnas.251539598","article-title":"High-level HIV-1 viremia suppresses viral antigen-specific CD4(+) T cell proliferation.","volume":"98","author":"McNeil","year":"2001","journal-title":"Proc Natl Acad Sci USA"},{"key":"R32-12-20210131","doi-asserted-by":"crossref","first-page":"10900","DOI":"10.1128\/JVI.77.20.10900-10909.2003","article-title":"Diminished proliferation of human immunodeficiency virus-specific CD4+ T cells is associated with diminished interleukin-2 (IL-2) production and is recovered by exogenous IL-2.","volume":"77","author":"Iyasere","year":"2003","journal-title":"J Virol"},{"key":"R33-12-20210131","doi-asserted-by":"crossref","first-page":"11486","DOI":"10.1128\/JVI.00324-06","article-title":"Diminished production of monocyte proinflammatory cytokines during human immunodeficiency virus viremia is mediated by type I interferons.","volume":"80","author":"Tilton","year":"2006","journal-title":"J Virol"},{"key":"R34-12-20210131","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1046\/j.1464-2662.2001.00096.x","article-title":"Levels of IL-6 and soluble IL-6 receptor are increased in HIV patients with a history of immune restoration disease after HAART.","volume":"3","author":"Stone","year":"2002","journal-title":"HIV Med"},{"key":"R35-12-20210131","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1007\/s11904-007-0003-z","article-title":"Disorders of immune reconstitution in patients with HIV infection responding to antiretroviral therapy.","volume":"4","author":"French","year":"2007","journal-title":"Curr HIV\/AIDS Rep"},{"key":"R37-12-20210131","doi-asserted-by":"crossref","first-page":"2051","DOI":"10.1097\/01.aids.0000247578.08449.ff","article-title":"An updated systematic overview of triple combination therapy in antiretroviral-naive HIV-infected adults.","volume":"20","author":"Bartlett","year":"2006","journal-title":"AIDS"},{"key":"R38-12-20210131","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1007\/s10495-007-0755-3","article-title":"HIV protease inhibitors modulate apoptosis signaling in vitro and in vivo.","volume":"12","author":"Vlahakis","year":"2007","journal-title":"Apoptosis"},{"key":"R39-12-20210131","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1172\/JCI2691","article-title":"In vivo analysis of Fas\/FasL interactions in HIV-infected patients.","volume":"102","author":"Badley","year":"1998","journal-title":"J Clin Invest"},{"key":"R40-12-20210131","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1182\/blood.V96.1.250.013k28_250_258","article-title":"HIV protease inhibitors restore impaired T-cell proliferative response in vivo and in vitro: a viral-suppression-independent mechanism.","volume":"96","author":"Lu","year":"2000","journal-title":"Blood"}],"container-title":["JAIDS Journal of Acquired Immune Deficiency Syndromes"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/journals.lww.com\/00126334-200712010-00012","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,8]],"date-time":"2025-02-08T00:00:27Z","timestamp":1738972827000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00126334-200712010-00012"}},"subtitle":["Risk Factors and Treatment Implications"],"short-title":[],"issued":{"date-parts":[[2007,12,1]]},"references-count":39,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2007]]}},"URL":"https:\/\/doi.org\/10.1097\/qai.0b013e3181594c8c","relation":{},"ISSN":["1525-4135"],"issn-type":[{"value":"1525-4135","type":"print"}],"subject":[],"published":{"date-parts":[[2007,12,1]]}}}